FindTrial
Sign In

Expert Opinion on the Proper Use of Teduglutide as Treatment for Short Bowel Syndrome in Adult Patients

Expert Opinion on the Proper Use of Teduglutide as Treatment for Short Bowel Syndrome in Adult Patients - Expert Opinion on the Proper Use of Teduglutide as Treatment for Short Bowel Syndrome in Adult Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000052594
Enrollment
10
Registered
2023-10-24
Start date
2023-12-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

short bowel syndrome

Interventions

None listed

Sponsors

Takeda Pharmaceutical Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Panelist should have at least 6 months of continuous experience in managing adult SBS patients in the clinical trial or in their routine clinical practice 2. Panelist should belong to a scientific society/conference related to SBS and have the following responsibilities: Professor, associate professor, lecturer, assistance professor, hospital director/ vice director, head/ vice head of department, head of medical office, or person with equivalent responsibility. 3. Panelist should have authored Japanese or International publication/s related to intestinal failure and/or SBS, or made oral/poster presentation in an SBS-related conference. 4. Panelist should have practical experience using TED, either through participation in the clinical trial or in their routine clinical practice * Participants who meet the selection criteria will be selected as panelists.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
An expert opinion on appropriate treatment of adult SBS with TED—

Countries

Japan

Contacts

Public ContactYu Osada

Takeda Pharmaceutical Company Limited Japan Medical Office

yu.osada@takeda.com03-3242-1256

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026